Long-term use of cyclosporine in liver recipients. Reduction of dosages in the first year to avoid nephrotoxicity

scientific article published on December 1, 1983

Long-term use of cyclosporine in liver recipients. Reduction of dosages in the first year to avoid nephrotoxicity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00007890-198336060-00010
P8608Fatcat IDrelease_dl4ftmmcs5dyleyro242pjj7la
P953full work available at URLhttps://europepmc.org/articles/PMC2965582
https://journals.lww.com/transplantjournal/Abstract/1983/36060/LONG_TERM_USE_OF_CYCLOSPORINE_IN_LIVER_RECIPIENTS_.10.aspx
https://europepmc.org/articles/PMC2965582?pdf=render
http://journals.lww.com/00007890-198336060-00010
P932PMC publication ID2965582
P698PubMed publication ID6362139
P5875ResearchGate publication ID16834430

P50authorThomas E. StarzlQ1248240
P2093author name stringS. Iwatsuki
S. L. Yang
B. W. Shaw
B. J. Zitelli
J. C. Gartner
J. J. Malatack
P2860cites workEvolution of liver transplantationQ34275840
The use of cyclosporin A and prednisone in cadaver kidney transplantationQ37305573
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 liversQ39574059
Nephrotoxicity of cyclosporin A in liver and kidney transplant patientsQ42588161
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectcyclosporineQ367700
P304page(s)641-643
P577publication date1983-12-01
P1433published inTransplantationQ15730500
P1476titleLong-term use of cyclosporine in liver recipients. Reduction of dosages in the first year to avoid nephrotoxicity
P478volume36

Reverse relations

cites work (P2860)
Q39629956A pediatric perspective on liver transplantation.
Q34236018Changes in life-style after liver transplantation
Q44052061Concomitant basiliximab with low-dose calcineurin inhibitors in children post-liver transplantation
Q39699974Cyclosporine conversion
Q39689835Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring
Q45252813Effect of cyclosporin A on T cell immunity. I. Dose-dependent suppression of different murine T helper cell pathways
Q44862290Effects of topical cyclosporin A on guinea-pig toxic contact dermatitis
Q41339331Hepatic Homograft Survival in Pediatric Orthotopic Liver Transplantation with Cyclosporine and Steroids
Q40966829Liver transplantation and its long-term management in children
Q39651580Liver transplantation: an overview